Staphylococcus aureus capsular polysaccharide type 5 conjugate and whole cell vaccines stimulate antibody responses in cattle

Vaccine

Volumn 19, Issue 28-29, 2001, Pages 3896-3903

  Tollersrud, Tore ^a   Zernichow, Lillian ^a   Andersen, Svein Rune ^b   Kenny, Kevin ^c   Lund, Arve ^a,d  

^a NORWEGIAN VETERINARY INSTITUTE   (Norway)

^b EDWARD JENNER INST FOR VACC RES   (United Kingdom)

^c Key Laboratories Ltd   (Ireland)

^d NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

Author keywords

Bovine; Mastitis; Polysaccharide; Serotype; Staphylococcus aureus; Vaccine

Indexed keywords

CAPSULAR POLYSACCHARIDE TYPE 5; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INACTIVATED VACCINE; MINERAL OIL; POLYSACCHARIDE; SODIUM CHLORIDE; STAPHYLOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CATTLE; CONTROLLED STUDY; HUMORAL IMMUNITY; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL CAPSULES; BACTERIAL VACCINES; CATTLE; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LYMPHOCYTE ACTIVATION; SERUM ALBUMIN; STAPHYLOCOCCUS AUREUS; VACCINES, CONJUGATE; VACCINES, INACTIVATED;

EID: 0035898944     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00124-4     Document Type: Article

References (49)

1. Outcome of clinical mastitis in dairy heifers assessed by reexamination of cases one month after treatment
2. The enhancement of mammary gland immunity through vaccination
3. Defences of the bovine mammary gland against infection and prospects for their enhancement
4. Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B
5. Antibody concentration and clinical protection after hib conjugate vaccination in the United Kingdom
6. Phagocytic killing of encapsulated and microencapsulated Staphylococcus aureus by human polymorphonuclear leukocytes
7. Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model
8. Virulence studies, in mice, of transposon-induced mutants of Staphylococcus aureus differing in capsule size
9. Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes
10. Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes
11. The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis
12. Capsular polysaccharides of Staphylococcus aureus
13. Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A
14. A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge
15. Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats
16. Isolation of type 5 capsular polysaccharide from Staphylococcus aureus
17. Purification and characterization of Staphylococcus aureus type 8 capsular polysaccharide
18. Structure of the type 5 capsular polysaccharide of Staphylococcus aureus
19. Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus
20. Serotyping and electron microscopy studies of Staphylococcus aureus clinical isolates with monoclonal antibodies to capsular polysaccharide types 5 and 8
21. Prevalence of capsular polysaccharide types 5 and 8 among Staphylococcus aureus isolates from cow, goat, and ewe milk
22. Capsule expression by bovine isolates of Staphylococcus aureus from Argentina: Genetic and epidemiologic analyses
23. Genetic and serologic evaluation of capsule production by bovine mammary isolates of Staphylococcus aureus and other Staphylococcus spp. from Europe and the United States
24. Vaccines and diagnostic methods for bovine mastitis: Fact and fiction
25. Prevention of clinical coliform mastitis in dairy cows by a mutant Escherichia coli vaccine
26. Efficacy of an Escherichia coli J5 bacterin administered to primigravid heifers
27. Virulence factors involved in the pathogenesis of bovine intramammary infections due to Staphylococcus aureus
28. Staphylococcal capsules and slime
29. Polysaccharide-protein conjugates: A new generation of vaccines
30. Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A
31. Immunogenicity in cows of Staphylococcus aureus type 5 capsular polysaccharide-ovalbumin conjugate
32. Immune recruitment and bactericidal activity of neutrophils in milk of cows vaccinated with staphylococcal α-toxin
33. Conjugation of capsular polysaccharide to alpha-haemolysin from Staphylococcus aureus as a glycoprotein antigen
34. Effect of conjugation methodology, carrier protein, and adjuvants on the immune response to Staphylococcus aureus capsular polysaccharides
35. Comparative immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or N-succinimidyl-3-(2-pyridyldithio)propionate
36. Immunogenicity in mice of multivalent conjugates composed of Staphylococcus aureus type 5 and 8 capsular polysaccharides and α and β toxins
37. The direct coupling of oligosaccharides to proteins and derivatized gels
38. Virulence of Staphylococcus aureus mutants altered in type 5 capsule production
39. ELISA methodology for polysaccharide antigens: Protein coupling of polysaccharides for adsorption to plastic tubes
40. A whole blood method for measuring mitogen-induced transformation of sheep lymphocytes
41. Characterisation of isolates of Staphylococcus aureus from acute, chronic and subclinical mastitis in cows in Norway
42. Isotype antibody response in cows to Streptococcus agalactiae group B polysaccharide-ovalbumin conjugate
43. Vaccination against experimental staphylococcal mastitis in dairy heifers
44. The effect of cytophilic IgG2 on phagocytosis by ovine polymorphonuclear leucocytes
45. Functional properties of bovine IgG1 and IgG2: Interaction with complement, macrophages, neutrophils and skin
46. Surface receptors for immunoglobulin on bovine polymorphonuclear neutrophils and macrophages
47. Relationship between serologic recognition of Escherichia coli 0111:B4 (J5) and clinical coliform mastitis in cattle
48. Antibody titres against CP5 and CP8 in a dairy herd with high incidence of Staphylococcus aureus mastitis
49. Production of antibodies to Staphylococcus aureus serotypes 5, 8, and 336 using poly(DL-lactide-co-glycolide) microspheres